Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China
· Delayed Price · Currency is CNY 90.59
+1.83 (2.06%)
Apr 2, 2025, 1:45 PM CST
SHA:688578 Market Cap
SHA:688578 has a market cap or net worth of 39.94 billion as of April 1, 2025. Its market cap has increased by 100.27% in one year.
Market Cap
39.94B
Enterprise Value
36.91B
Revenue
3.56B
Ranking
n/a
PE Ratio
28.09
Stock Price
90.59
Market Cap Chart
Since December 2, 2020, SHA:688578's market cap has increased from 17.35B to 39.94B, an increase of 130.25%. That is a compound annual growth rate of 21.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 39.94B | 48.18% |
| Dec 31, 2024 | 26.96B | 43.78% |
| Dec 29, 2023 | 18.75B | 111.69% |
| Dec 30, 2022 | 8.86B | -34.83% |
| Dec 31, 2021 | 13.59B | 6.04% |
| Dec 31, 2020 | 12.82B | -26.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 312.84B |
| Shenzhen Mindray Bio-Medical Electronics | 283.00B |
| WuXi AppTec | 193.37B |
| Aier Eye Hospital Group | 123.47B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.02B |
| Yunnan Baiyao Group Co.,Ltd | 101.35B |
| Shanghai United Imaging Healthcare | 99.90B |
| Sichuan Biokin Pharmaceutical | 93.16B |